Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year

By SquaredTown on March 31, 2026

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year

New subscription-based option helps eligible self-pay patients start and stay on Wegovy® with predictable pricing Available March 31, 2026, through Ro, WeightWatchers, LifeMD, with Hims & Hers, Sesame, and other telehealth providers coming online soon Program builds on Novo Nordisk's...

Read More